Realtek Semiconductor (2379) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue reached TWD 35.02 billion, up 32.94% sequentially and 37% year-over-year, driven by customer restocking and robust IC demand.

• Gross margin improved to 52%, a 3.21 percentage point increase quarter-over-quarter and up from 51% year-over-year, attributed to a favorable product mix.

• Operating profit was TWD 4.90 billion (14% margin), up 70.3% quarter-over-quarter and 79% year-over-year; net profit was TWD 4.76 billion (13.6% margin), with EPS at TWD 9.28.

• Inventory turnover days dropped to 75, reflecting healthy inventory levels after Q4's planned buildup for tariff-related order pull-ins.

• Earnings per share increased to TWD 9.28 (basic) and TWD 9.14 (diluted), compared to TWD 6.10 and TWD 6.05 in Q1 2024.

Financial highlights

• Operating revenue: TWD 35.02 billion (Q1 2025), up from TWD 25.6 billion (Q1 2024).

• Operating expenses increased to TWD 13.15 billion, mainly due to higher R&D and employee costs, representing 37.6% of revenue.

• Non-operating income was TWD 702 million, down from TWD 762 million in Q4, mainly due to reduced government subsidies.

• Cash and cash equivalents at quarter-end: TWD 10.57 billion, down from TWD 14.81 billion at year-end 2024.

• Cash dividends of TWD 25.50 per share for 2024 were declared, totaling TWD 13.08 billion.

Outlook and guidance

• Q2 may see continued defensive stocking by customers amid ongoing international uncertainties; vigilant monitoring of end market demand is planned.

• Full-year PC shipment growth for 2025 is expected to be modest or potentially decline, depending on tariff impacts and inventory normalization.

• Gross margin sustainability depends on product mix; prolonged tariffs could pressure margins, but focus remains on high-value, AI-enabled products.

• OPEX ratio is expected to decline in the medium to long term despite anticipated R&D expense growth.

• Management expects continued growth, supported by robust demand for integrated circuit products and ongoing R&D investments.